Karava V, Kondou A, Dotis J, Sotiriou G, Gerou S, Michelakakis H
Children (Basel). 2021; 8(2).
PMID: 33562640
PMC: 7915400.
DOI: 10.3390/children8020112.
Madaan P, Jauhari P, Michael S, Sinha A, Chakrabarty B, Gulati S
Ann Indian Acad Neurol. 2020; 23(1):136-138.
PMID: 32055141
PMC: 7001442.
DOI: 10.4103/aian.AIAN_166_19.
Bagga A, Khandelwal P, Mishra K, Thergaonkar R, Vasudevan A, Sharma J
Pediatr Nephrol. 2019; 34(8):1465-1482.
PMID: 30989342
DOI: 10.1007/s00467-019-04233-7.
Keyfi F, Abbaszadegan M, Sankian M, Rolfs A, Orolicki S, Pournasrollah M
Mol Biol Rep. 2019; 46(1):271-285.
PMID: 30712249
DOI: 10.1007/s11033-018-4469-0.
Bu F, Zhang Y, Wang K, Ghiringhelli Borsa N, Jones M, Taylor A
J Am Soc Nephrol. 2018; 29(12):2809-2819.
PMID: 30377230
PMC: 6287871.
DOI: 10.1681/ASN.2018070759.
Cobalamin C Deficiency Induces a Typical Histopathological Pattern of Renal Arteriolar and Glomerular Thrombotic Microangiopathy.
Lemoine M, Francois A, Grange S, Rabant M, Chatelet V, Cassiman D
Kidney Int Rep. 2018; 3(5):1153-1162.
PMID: 30197982
PMC: 6127440.
DOI: 10.1016/j.ekir.2018.05.015.
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.
Brocklebank V, Kavanagh D
Clin Kidney J. 2017; 10(5):600-624.
PMID: 28980670
PMC: 5622895.
DOI: 10.1093/ckj/sfx081.
Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.
Allinovi M, Cirami C, Caroti L, Antognoli G, Farsetti S, Amato M
Clin Kidney J. 2017; 10(5):625-631.
PMID: 28980667
PMC: 5622889.
DOI: 10.1093/ckj/sfw143.
Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients.
Liu J, Peng Y, Zhou N, Liu X, Meng Q, Xu H
Orphanet J Rare Dis. 2017; 12(1):58.
PMID: 28327205
PMC: 5360033.
DOI: 10.1186/s13023-017-0610-8.
Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls.
Vaisbich M, Braga A, Gabrielle M, Bueno C, Piazzon F, Kok F
Pediatr Nephrol. 2017; 32(6):1089-1092.
PMID: 28210839
DOI: 10.1007/s00467-017-3615-6.
Renal thrombotic microangiopathy in patients with cblC defect: review of an under-recognized entity.
Beck B, van Spronsen F, Diepstra A, Berger R, Komhoff M
Pediatr Nephrol. 2016; 32(5):733-741.
PMID: 27289364
PMC: 5368212.
DOI: 10.1007/s00467-016-3399-0.
An unusual cause of hypertension with hematuria and proteinuria: Answers.
Stokes M, Zviti R, Lin F, DAgati V
Pediatr Nephrol. 2016; 31(12):2265-2270.
PMID: 26980089
DOI: 10.1007/s00467-016-3348-y.
Advances and challenges in the management of complement-mediated thrombotic microangiopathies.
Davin J, van de Kar N
Ther Adv Hematol. 2015; 6(4):171-85.
PMID: 26288712
PMC: 4530367.
DOI: 10.1177/2040620715577613.
Clinical characteristics of hemolytic uremic syndrome secondary to cobalamin C disorder in Chinese children.
Li Q, Song W, Peng X, Liu X, He L, Fu L
World J Pediatr. 2015; 11(3):276-80.
PMID: 26253414
DOI: 10.1007/s12519-015-0032-4.
An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
Loirat C, Fakhouri F, Ariceta G, Besbas N, Bitzan M, Bjerre A
Pediatr Nephrol. 2015; 31(1):15-39.
PMID: 25859752
DOI: 10.1007/s00467-015-3076-8.
Three new cases of late-onset cblC defect and review of the literature illustrating when to consider inborn errors of metabolism beyond infancy.
Huemer M, Scholl-Burgi S, Hadaya K, Kern I, Beer R, Seppi K
Orphanet J Rare Dis. 2014; 9:161.
PMID: 25398587
PMC: 4255922.
DOI: 10.1186/s13023-014-0161-1.
Atypical glomerulopathy associated with the cblE inborn error of vitamin B₁₂ metabolism.
Paul E, Guttenberg M, Kaplan P, Watkins D, Rosenblatt D, Treat J
Pediatr Nephrol. 2013; 28(7):1135-9.
PMID: 23503767
DOI: 10.1007/s00467-013-2443-6.
Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria.
Menni F, Testa S, Guez S, Chiarelli G, Alberti L, Esposito S
Pediatr Nephrol. 2012; 27(8):1401-5.
PMID: 22447314
DOI: 10.1007/s00467-012-2152-6.
Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
Geerdink L, Westra D, van Wijk J, Dorresteijn E, Lilien M, Davin J
Pediatr Nephrol. 2012; 27(8):1283-91.
PMID: 22410797
PMC: 3382652.
DOI: 10.1007/s00467-012-2131-y.
Atypical hemolytic uremic syndrome.
Loirat C, Fremeaux-Bacchi V
Orphanet J Rare Dis. 2011; 6:60.
PMID: 21902819
PMC: 3198674.
DOI: 10.1186/1750-1172-6-60.
